Tourmaline Bio Inc
NASDAQ:TRML

Watchlist Manager
Tourmaline Bio Inc Logo
Tourmaline Bio Inc
NASDAQ:TRML
Watchlist
Price: 47.98 USD
Market Cap: 1.2B USD

Wall Street
Price Targets

TRML Price Targets Summary
Tourmaline Bio Inc

There are no price targets for TRML.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Tourmaline Bio Inc Competitors:
Price Targets
BSLN
Basilea Pharmaceutica AG
46% Upside
DVAX
Dynavax Technologies Corp
90% Upside
TNG
Transgene SA
54% Upside
4587
PeptiDream Inc
96% Upside
ORKA
Oruka Therapeutics Inc
57% Upside
6628
Transcenta Holding Limited
553% Upside
ACAD
ACADIA Pharmaceuticals Inc
6% Upside
688177
Bio-Thera Solutions Ltd
55% Upside

Revenue
Forecast

Revenue Estimate
Tourmaline Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tourmaline Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Tourmaline Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRML's stock price target?
Not Available

TRML doesn't have any price targets made by Wall Street professionals.

Back to Top